CEO Bobby Gasoar, MD, PhD, made his presence felt at Orchard Therapeutics in May, leading the company in carrying out a strategic plan that included eliminating about 25% of its workforce, or 60 jobs, and narrowing its near-term R&D pipeline programs to four . . .

Get GEN Edge Today!

The post At Orchard, Moving from Pruning to Planting appeared first on GEN – Genetic Engineering and Biotechnology News.